Glimepiride induces nitric oxide production in human coronary artery endothelial cells via a PI3-kinase-Akt dependent pathway

Atherosclerosis

Volumn 183, Issue 1, 2005, Pages 35-39

  Ueba, Hiroto ^a   Kuroki, Masatoshi ^a   Hashimoto, Shigemasa ^a   Umemoto, Tomio ^a   Yasu, Takanori ^a   Ishikawa, San E ^a   Saito, Muneyasu ^a   Kawakami, Masanobu ^a  

^a JICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

Atherosclerosis; Endothelium; Nitric oxide; Signal transduction; Sulfonylurea

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; ANTISENSE OLIGODEOXYNUCLEOTIDE; GLIBENCLAMIDE; GLIMEPIRIDE; GLUCOSE; NITRIC OXIDE; PROTEIN KINASE B; PROTEIN KINASE INHIBITOR;

ARTERY ENDOTHELIUM; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY; DRUG EFFECT; DRUG INHIBITION; ENDOTHELIUM CELL; ENZYME ACTIVATION; GLUCOSE BLOOD LEVEL; HUMAN; HUMAN CELL; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; VASCULAR ENDOTHELIUM; WESTERN BLOTTING;

1-PHOSPHATIDYLINOSITOL 3-KINASE; CELLS, CULTURED; CHROMONES; CORONARY VESSELS; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; ENZYME ACTIVATION; GLYBURIDE; HUMANS; HYPOGLYCEMIC AGENTS; MORPHOLINES; NITRIC OXIDE; OLIGODEOXYRIBONUCLEOTIDES, ANTISENSE; PHOSPHORYLATION; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTO-ONCOGENE PROTEINS C-AKT; SIGNAL TRANSDUCTION; SULFONYLUREA COMPOUNDS;

EID: 26244444497     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2005.01.055     Document Type: Article

References (18)

1. E. Bierman George Lyman Duff Memorial Lecture. Atherogenesis in diabetes Arterioscler Thromb 12 6 1992 647 656
2. M. Laakso, and S. Lehto Epidemiology of risk factors for cardiovascular disease in diabetes and impaired glucose tolerance Atherosclerosis 137 Suppl. 1998 65 73
3. S. Woodfield, C. Lundergan, and J. Reiner Angiographic findings and outcome in diabetic patients treated with thrombolytic therapy for acute myocardial infarction: the GUSTO-I experience J Am Coll Cardiol 28 7 1996 1661 1669
4. H. del Valle, E. Lascano, J. Negroni, and A.J. Crottogini Glibenclamide effects on reperfusion-induced malignant arrhythmias and left ventricular mechanical recovery from stunning in conscious sheep Cardiovasc Res 50 3 2001 474 485
5. K. Geisen, A. Vegh, E. Krause, and J.G. Papp Cardiovascular effects of conventional sulfonylureas and glimepiride Horm Metab Res 28 9 1996 496 507
6. J. Riveline, N. Danchin, F. Ledru, M. Varroud-Vial, and G. Charpentier Sulfonylureas and cardiovascular effects: from experimental data to clinical use. Available data in humans and clinical applications Diab Metab 29 3 2003 207 222
7. S. Shakuto, Y. Sato, K. Ohshima, and M. Yaguchi Atheroprotective effects of a new sulfonylurea of the third generation, glimepiride Diabetic Complications 15 Suppl. 1 2001 68
8. G. Muller, C. Jung, S. Wied, S. Welte, and W. Frick Insulin-mimetic signaling by the sulfonylurea glimepiride and phosphoinositolglycans involves distinct mechanisms for redistribution of lipidraft components Biochemistry 40 48 2001 14603 14620
9. Y. Maejima, H. Ueba, and M. Kuroki Src family kinases and nitric oxide production are required for hepatocyte growth factor-stimulated endothelial cell growth Atherosclerosis 167 1 2003 89 95
10. A. Hiraoka, Y. Masuya, and I. Tominaga Simultaneous determination by high-performance liquid chromatography of nitrite and nitrate in cerebrospinal fluid and serum from patients with neurological disorders Chromatography 20 1 1999 45 49
11. H. Ueba, V. Poppa, J. Suero, M. Okuda, and B.C. Berk c-Src is required for flow-stimulated NO production in bovine aortic endothelial cells Circulation 98 17 1998 I-312
12. B.C.G. Gallis, D.R. Goodlett, and H. Ueba Identification of flow-dependent endothelial nitric-oxide synthase phosphorylation sites by mass spectrometry and regulation of phosphorylation and nitric oxide production by the phosphatidylinositol 3-kinase inhibitor LY294002 J Biol Chem 274 42 1999 30101 30108
13. W. Aengevaeren Beyond lipids - the role of the endothelium in coronary artery disease Atherosclerosis 147 Suppl. 1 1999 11 16
14. D. Fulton, J. Gratton, and T.J. McCabe Regulation of endothelium-derived nitric oxide production by the protein kinase Akt Nature 399 6736 1999 597 601
15. A. Skaletz-Rorowski, M. Lutchman, Y. Kureishi, D. Lefer, J. Faust, and K. Walsh HMG-CoA reductase inhibitors promote cholesterol-dependent Akt/PKB translocation to membrane domains in endothelial cells Cardiovasc Res 57 1 2003 253 264
16. D.K. Song, and F.M. Ashcroft Glimepiride block of cloned beta-cell, cardiac and smooth muscle K (ATP) channels Br J Pharmacol 133 1 2001 193 199
17. G. Muller, C. Jung, W. Frick, W. Bandlow, and W. Kramer Interaction of phosphatidylinositolglycan(-peptides) with plasma membrane lipid rafts triggers insulin-mimetic signaling in rat adipocytes Arch Biochem Biophys 408 1 2002 7 16
18. T.E. Peterson, V. Poppa, H. Ueba, A. Wu, C. Yan, and B.C. Berk Opposing effects of reactive oxygen species and cholesterol on endothelial NO synthase and endothelial cell caveolae Circ Res 85 1999 29 37